Food manufacturers are increasingly shifting toward precision-fermented and plant-based alternatives to secure their supply chains against the price spikes and functional variability inherent in traditional poultry farming. Recent large-scale depopulation events, including the loss of 50.7 million hens during avian-influenza outbreaks, have forced industry players to prioritize consistent, lab-grown proteins that mimic the binding and foaming properties of conventional egg whites.
Animal-Free Egg Protein Market Set for Rapid Expansion Through 2036
Driven by volatile poultry supplies and the threat of avian influenza, the global market for animal-free egg proteins is projected to grow from USD 287.4 million in 2026 to USD 1,933.5 million by 2036, representing a compound annual growth rate of 21.0%.

Precision-fermented ovalbumin currently leads the sector, capturing 56.1% of the market share in 2026. This technology allows producers to maintain identical protein behavior across batches, a critical requirement for large-scale bakery operations, which account for 38.0% of total demand. While liquid formats dominate current supply chains due to their ease of integration into existing kitchen infrastructure, the industry faces ongoing hurdles in navigating diverse international regulatory frameworks for novel foods. Singapore and the Netherlands are currently spearheading global growth, fueled by supportive pre-market approval processes and advanced food-processing logistics.



Comments (0)
No comments yet. Be the first!